RS49962B - Peroralne kompozicije koje kontrolisano oslobađaju levosimendan - Google Patents
Peroralne kompozicije koje kontrolisano oslobađaju levosimendanInfo
- Publication number
- RS49962B RS49962B YUP-639/00A YU63900A RS49962B RS 49962 B RS49962 B RS 49962B YU 63900 A YU63900 A YU 63900A RS 49962 B RS49962 B RS 49962B
- Authority
- RS
- Serbia
- Prior art keywords
- levosimendan
- controlled release
- peroral compositions
- release peroral
- less
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Abstract
Kompozicija za kontrolisano oslobađanje, naznačena time, što sadrži a) terapeutski efikasnu količinu levosimendana i b) komponentu koja kontroliše oslobađanje leka za obezbeđivanje oslobađanja levosimendana u toku produženog perioda vremena i stabilnog stanja nivoa u plazmi metabolita (II) od manje od 20 ng/ml, prvenstveno manje od 10 ng/ml Prijava sadrži još 8 zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI980901A FI980901A (fi) | 1998-04-23 | 1998-04-23 | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
Publications (2)
Publication Number | Publication Date |
---|---|
YU63900A YU63900A (sh) | 2003-07-07 |
RS49962B true RS49962B (sr) | 2008-09-29 |
Family
ID=8551575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-639/00A RS49962B (sr) | 1998-04-23 | 1999-04-23 | Peroralne kompozicije koje kontrolisano oslobađaju levosimendan |
Country Status (38)
Country | Link |
---|---|
US (1) | US7045147B1 (sr) |
EP (1) | EP1071397B1 (sr) |
JP (2) | JP4566402B2 (sr) |
KR (1) | KR100960597B1 (sr) |
CN (1) | CN1248691C (sr) |
AR (1) | AR019096A1 (sr) |
AT (1) | ATE258425T1 (sr) |
AU (1) | AU756641B2 (sr) |
BG (1) | BG64839B1 (sr) |
BR (1) | BR9909869A (sr) |
CA (1) | CA2329234C (sr) |
CO (1) | CO5070607A1 (sr) |
CZ (1) | CZ295194B6 (sr) |
DE (1) | DE69914472T2 (sr) |
DK (1) | DK1071397T3 (sr) |
EA (1) | EA002829B1 (sr) |
EE (1) | EE04220B1 (sr) |
ES (1) | ES2215379T3 (sr) |
FI (1) | FI980901A (sr) |
GE (1) | GEP20032906B (sr) |
HK (1) | HK1034032A1 (sr) |
HR (1) | HRP20000704B1 (sr) |
HU (1) | HUP0101458A3 (sr) |
ID (1) | ID27987A (sr) |
IL (2) | IL138951A0 (sr) |
MX (1) | MXPA00010367A (sr) |
NO (1) | NO329809B1 (sr) |
NZ (1) | NZ507453A (sr) |
PL (1) | PL197447B1 (sr) |
PT (1) | PT1071397E (sr) |
RS (1) | RS49962B (sr) |
SI (1) | SI1071397T1 (sr) |
SK (1) | SK285427B6 (sr) |
TR (1) | TR200003102T2 (sr) |
TW (1) | TWI224507B (sr) |
UA (1) | UA68376C2 (sr) |
WO (1) | WO1999055305A2 (sr) |
ZA (1) | ZA200005632B (sr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20011465A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Pyridatsinonijohdannaisen uusi käyttö |
BRPI0408323A (pt) * | 2003-03-14 | 2006-03-07 | Nirmal Mulye | processo para a preparação de compimidos de liberação prolongada |
FI20070521L (fi) * | 2006-11-10 | 2008-05-11 | Atacama Labs Oy | Rakeita, tabletteja ja rakeistusmenetelmä |
CN107029220A (zh) | 2008-06-30 | 2017-08-11 | 托卡根公司 | 5‑氟胞嘧啶制剂及其用途 |
JP2014172850A (ja) * | 2013-03-07 | 2014-09-22 | Capsugel Belgium Nv | ハードカプセル製剤 |
CN105784895B (zh) * | 2015-10-30 | 2018-05-22 | 成都欣捷高新技术开发有限公司 | 一种用高效液相色谱仪检测左西孟旦中杂质的方法 |
JP2023507626A (ja) | 2019-12-16 | 2023-02-24 | テナックス・セラピューティクス,インコーポレイテッド | 駆出率が保たれた心不全を伴う肺高血圧症(PH-HF-pEF)を治療するためのレボシメンダン |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ203684A (en) | 1982-04-05 | 1986-06-11 | Merck Sharp & Dohme | Granular formulation for the stabilization of unstable drugs or food supplements |
US4716042A (en) | 1986-06-16 | 1987-12-29 | American Home Products Corporation | Stabilized coated aspirin tablets |
GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
US5213811A (en) * | 1991-09-13 | 1993-05-25 | Sterling Drug Inc. | Oral sustained-release drug compositions |
GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
GB9614098D0 (en) | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
FI973804A (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
FI974578A (fi) * | 1997-12-19 | 1999-06-20 | Orion Yhtymae Oyj | Menetelmä levosimendaanin antamiseksi |
FI980902A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaanin stabiileja koostumuksia |
-
1998
- 1998-04-23 FI FI980901A patent/FI980901A/fi unknown
-
1999
- 1999-03-26 CO CO99018533A patent/CO5070607A1/es unknown
- 1999-04-09 TW TW088105661A patent/TWI224507B/zh not_active IP Right Cessation
- 1999-04-22 AR ARP990101869A patent/AR019096A1/es active IP Right Grant
- 1999-04-23 KR KR1020007011788A patent/KR100960597B1/ko not_active IP Right Cessation
- 1999-04-23 JP JP2000545505A patent/JP4566402B2/ja not_active Expired - Fee Related
- 1999-04-23 PL PL344078A patent/PL197447B1/pl not_active IP Right Cessation
- 1999-04-23 BR BR9909869-5A patent/BR9909869A/pt not_active Application Discontinuation
- 1999-04-23 DE DE69914472T patent/DE69914472T2/de not_active Expired - Lifetime
- 1999-04-23 AU AU35246/99A patent/AU756641B2/en not_active Ceased
- 1999-04-23 ID IDW20002367A patent/ID27987A/id unknown
- 1999-04-23 MX MXPA00010367A patent/MXPA00010367A/es unknown
- 1999-04-23 US US09/673,794 patent/US7045147B1/en not_active Expired - Fee Related
- 1999-04-23 CA CA002329234A patent/CA2329234C/en not_active Expired - Fee Related
- 1999-04-23 ES ES99916941T patent/ES2215379T3/es not_active Expired - Lifetime
- 1999-04-23 DK DK99916941T patent/DK1071397T3/da active
- 1999-04-23 NZ NZ507453A patent/NZ507453A/xx unknown
- 1999-04-23 EP EP99916941A patent/EP1071397B1/en not_active Expired - Lifetime
- 1999-04-23 UA UA2000116616A patent/UA68376C2/uk unknown
- 1999-04-23 SK SK1554-2000A patent/SK285427B6/sk not_active IP Right Cessation
- 1999-04-23 EA EA200001098A patent/EA002829B1/ru not_active IP Right Cessation
- 1999-04-23 GE GEAP19995639A patent/GEP20032906B/en unknown
- 1999-04-23 CN CNB998064181A patent/CN1248691C/zh not_active Expired - Fee Related
- 1999-04-23 SI SI9930536T patent/SI1071397T1/xx unknown
- 1999-04-23 AT AT99916941T patent/ATE258425T1/de not_active IP Right Cessation
- 1999-04-23 EE EEP200000617A patent/EE04220B1/xx not_active IP Right Cessation
- 1999-04-23 WO PCT/FI1999/000329 patent/WO1999055305A2/en not_active Application Discontinuation
- 1999-04-23 RS YUP-639/00A patent/RS49962B/sr unknown
- 1999-04-23 IL IL13895199A patent/IL138951A0/xx active IP Right Grant
- 1999-04-23 TR TR2000/03102T patent/TR200003102T2/xx unknown
- 1999-04-23 HU HU0101458A patent/HUP0101458A3/hu unknown
- 1999-04-23 PT PT99916941T patent/PT1071397E/pt unknown
- 1999-04-23 CZ CZ20003780A patent/CZ295194B6/cs not_active IP Right Cessation
-
2000
- 2000-10-11 IL IL138951A patent/IL138951A/en not_active IP Right Cessation
- 2000-10-12 ZA ZA200005632A patent/ZA200005632B/en unknown
- 2000-10-19 HR HR20000704A patent/HRP20000704B1/xx not_active IP Right Cessation
- 2000-10-20 NO NO20005313A patent/NO329809B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104959A patent/BG64839B1/bg unknown
-
2001
- 2001-02-14 HK HK01101050A patent/HK1034032A1/xx not_active IP Right Cessation
-
2010
- 2010-01-12 JP JP2010004367A patent/JP2010083900A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50035B (sr) | Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje | |
RS50031B (sr) | Triciklični inhibitori poli(adp-riboza)polimeraza | |
NZ314442A (en) | Extended release formulation comprising venlafaxine hydrochloride, film coating composition | |
RS49993B (sr) | Postupak za dobijanje (-)-4-amino-5-fluoro-1-(2-hidroksimetil-1,3-oksatiolan-5-il)-(1h)-pirimidin-2-ona | |
ID28658A (id) | Senyawa yang menghambat pengikatan integrin pada reseptornya | |
NZ315006A (en) | Paroxetine controlled release compositions | |
IL98033A0 (en) | Pharmaceutical compositions including a non-steroidal anti-inflammatory drug and a prostaglandin | |
DK1102588T3 (da) | Farmaceutiske sammensætninger til forebyggelse og behandling af sygdomme i centralnervesystemet indeholdende en nikotinanalog og en acetylcholinesteraseinhibitor | |
IL143673A0 (en) | Compositions comprising 1,1,1,3,3-pentaflurobutane and use of said compositions | |
CY1112517T1 (el) | Φαρμακοτεχνικες μορφες τροποποιημενης αποδεσμευσης μιας τουλαχιστον μορφης τραμαδολης | |
HUP9802506A2 (hu) | A ciklooxigenáz-2 (COX-2) enzimet gátló (metil-szulfonil)-fenil-2-(5H)-furanon-származékok és alkalmazásuk, valamint ezeket tartalmazó gyógyászati készítmény | |
ATE240721T1 (de) | Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten | |
FI941396A0 (fi) | Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten | |
DE69403656D1 (de) | Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph | |
DE60037726D1 (de) | Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen | |
RS49723B (sr) | Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze | |
ID24632A (id) | Komposisi penyalutan sangat padat | |
RS50116B (sr) | Lokalne farmaceutske kompozicije koje sadrže nimesulid | |
RS49962B (sr) | Peroralne kompozicije koje kontrolisano oslobađaju levosimendan | |
AU1843397A (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents | |
DK1305037T3 (da) | Smertestillende medikament | |
DK0701449T3 (da) | Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac | |
DZ1576A1 (fr) | Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione. | |
NO982229D0 (no) | Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler | |
ZA981430B (en) | Anticancer composition |